Introducing Fluvoxin. Fluvoxamine maleate 50/100 mg. The 1st Specific anti-obsessive therapy. First SSRI approved by US FDA to treat OCD in children and adolescents. Significantly improves Obsessive Compulsive symptoms. First SSRI that offers a favvourable tolerability profile. Lower incidence of Sexual Dysfunction. Effective adjuvant in Schizo-Obsessive Patients.
Abstract
Fluvoxamine maleate, Symbiosis - Sun Pharmaceutical Industry, Man walking out of a maze. Cannot see his face clearly. Looks like he has scissors in his hands to trim the leaves in the maze.
